Osteoporotic fractures in older adults

Best Practice and Research: Clinical Rheumatology

Volumn 20, Issue 4, 2006, Pages 695-706

  Colón Emeric, Cathleen S ^a   Saag, Kenneth G ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

aged; fractures; osteoporosis

Indexed keywords

ACETYLSALICYLIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; COLECALCIFEROL; ENOXAPARIN; ERGOCALCIFEROL; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE SULFATE; NARCOTIC ANALGESIC AGENT; PARATHYROID HORMONE[1-34]; PLACEBO; RALOXIFENE; VITAMIN D;

ADULT; AGED; AGING; BLEEDING; BONE MASS; CLINICAL PROTOCOL; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DELIRIUM; DISABILITY; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FALLING; FRACTURE; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HUMAN; KYPHOPLASTY; LABORATORY TEST; META ANALYSIS; MORBIDITY; MORTALITY; OSTEOPOROSIS; PAIN; PERCUTANEOUS VERTEBROPLASTY; PRIORITY JOURNAL; PROTECTIVE CLOTHING; PUBLIC HEALTH; REHABILITATION CARE; REVIEW; SYSTEMATIC REVIEW; THROMBOEMBOLISM; VERTEBRA FRACTURE; VITAMIN D DEFICIENCY;

AGED; DELIRIUM; FRACTURES, BONE; FRACTURES, SPONTANEOUS; HEALTH EXPENDITURES; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PAIN; RISK ASSESSMENT; RISK FACTORS; THROMBOEMBOLISM;

EID: 33748469980     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2006.04.004     Document Type: Review

References (73)

1. US Department of Health and Human Services. Bone Health and Osteoporosis: a Report of the Surgeon General (2004), US Department of Health and Human Services, Office of the Surgeon General, Rockville, MD
2. Cooper C., Campion G., and Melton L. Hip fractures in the elderly: a world-wide projection. Osteoporosis International 2 (1992) 285-289
3. Cooper C., and Melton L. Epidemiology of osteoporosis. Trends in Endocrinology and Metabolism 3 (1992) 224-229
4. Diamond T., Thornley S., Sekel R., and Smerdely P. Hip fracture in elderly men: prognostic factors and outcomes. The Medical Journal of Australia 167 (1997) 412-415
5. Ray N., Chan J., Thamer M., and Melton L. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. Journal of Bone and Mineral Research 12 (1997) 24-35
6. Zimmerman S., Chandler J., Hawkes W., et al. Effect of fracture on the health care use of nursing home residents. Archives of Internal Medicine 162 (2002) 1502-1508
7. Salkeld G., Cameron I., Cumming R., et al. Quality of life related to fear of falling and hip fracture in older women. A time trade off study. BMJ 320 (2000) 341-346
8. Lyles K., Gold D., Shipp K., et al. Association of osteoporotic vertebral compression fractures with impaired functional status. The American Journal of Medicine 94 (1993) 595-601
9. Fox K., Hawkes W., Hebel J., et al. Mobility after hip fracture predicts health outcomes. Journal of the American Geriatrics Society 46 (1998) 169-173
10. Crans G., Silverman S., Genant H., et al. Association of severe vertebral fractures with reduced quality of life: reduction in the incidence of severe vertebral fractures by teriparatide. Arthritis and Rheumatism 50 (2004) 4028-4034
11. Picavet H., and Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Annals of the Rheumatic Diseases 63 (2004) 723-729
12. Handoll H., Farrar M., McBirnie J., et al. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database of Systematic Reviews 4 (2002) CD000305
13. Britt S., Barker D., Maxwell R., et al. The impact of pelvic and lower extremity fractures on the incidence of lower extremity deep vein thrombosis in high-risk trauma patients. The American Surgeon 69 (2003) 459-463
14. Turpie A., Bauer K., Eriksson B., and Lassen M. Fondaparinux vs enoxaparin for the prevention of venous thromboemolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Archives of Internal Medicine 162 (2002) 1833-1840
15. PEP Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention Trial. Lancet 355 (2000) 1295-1302
16. Eriksson B., Lassen M., and Colwell C.J. Efficacy of fondaparinux for thromboprophylaxis in hip fracture patients. The Journal of Arthroplasty 19 supplement 2 (2004) 78-81
17. Francis J. Delirium in older patients. Journal of the American Geriatrics Society 40 (1992) 829-838
18. Brauer C., Morrison R., Silberzweig S., and Siu A. The cause of delirium in patients with hip fracture. Archives of Internal Medicine 160 (2000) 1856-1860
19. Marcantonio E., Flacker J., Wright R., and Resnick N. Reducing delirium after hip fracture: a randomized trial. Journal of the American Geriatrics Society 49 (2001) 516-522
20. Edelstein D., Aharonoff G., Karp A., et al. Effect of postoperative delirium on outcome after hip fracture. Clinical Orthopaedics and Related Research 422 (2004) 195-200
21. Morrison R., and Siu A. A comparison of pain and its treatment in advanced dementia and cognitively intact patients with hip fracture. Journal of Pain and Symptom Management 19 (2000) 240-248
22. Morrison R., Magaziner J., Gilbert M., et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. The Journals of Gerontology. Series A 58 (2003) 76-81
23. Fink J., Ensrud K., Nelson D., et al. Disability after clinical fracture in postmenopausal women with low bone density: the Fracture Intervention Trial (FIT). Osteoporosis International 14 (2003) 69-76
24. Handoll H., Sherrington C., and Parker M. Mobilisation strategies after hip fracture surgery in adults. Cochrane Database of Systematic Reviews 4 (2004) CD001704
25. Penrod J., Boockvar K.L., Litke A., et al. Physical therapy and mobility 2 and 6 months after hip fracture. Journal of the American Geriatrics Society 52 (2004) 1114-1120
26. Hodgson S., Mawson S., and Stanley D. Rehabilitation after two-part fractures of the neck of the humerus. The Journal of Bone and Joint Surgery 85 (2003) 419-422
27. Liow R., Cregan A., Nanda R., and Montgomery R. Early mobilisation for minimally displaced radial head fractures is desirable. A prospective randomized study of two protocols. Injury 33 (2002) 801-806
28. Binder E., Brown M., Sincacore D., et al. Effects of extended outpatient rehabilitation after hip fracture: a randomized controlled trial. JAMA 292 (2004) 837-846
29. Tinetti M., Baker D., Gottschalk M., et al. Home-based multicomponent rehabilitation program for older persons after hip fracture: a randomized trial. Archives of Physical Medicine and Rehabilitation 80 (1999) 916-922
30. Gold D., Shipp K., Pieper C., et al. Group treatment improves trunk strength and psychological status in older women with vertebral fractures: results of a randomized clinical trial. Journal of the American Geriatrics Society 52 (2004) 1471-1478
31. Papaioannou A., Adachi J., Winegard K., et al. Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures. Osteoporosis International 14 (2003) 677-682
32. Diamond T., Champion B., and Clark W. Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous vertebroplasty with conservative therapy. The American Journal of Medicine 114 (2003) 257-265
33. Laredo J., and Hamze B. Complications of percutaneous vertebroplasty and their prevention. Skeletal Radiology 33 (2004) 493-505
34. Fribourg D., Tang C., Sra P., et al. Incidence of subsequent vertebral fracture after kyphoplasty. Spine 29 (2004) 2270-2276
35. Uppin A., Hirsch J., Centenera L., et al. Occurrence of new vertebral body fracture after percutaneous vertebroplasty in patients with osteoporosis. Radiologia 226 (2003) 119-124
36. Nelson H., Morris C., Kraemer D., et al. Osteoporosis in Postmenopausal Women: Diagnosis and Monitoring (2002), Agency for Healthcare Policy and Research, Rockville, MD
37. Kelepouris N., Harper K., Gannon F., et al. Severe osteoporosis in men. Annals of Internal Medicine 123 (1995) 452-460
38. Thomas M., Lloyd-Jones D., Thadhanai R., et al. Hypovitaminosis D in medical inpatients. The New England Journal of Medicine 3338 (1998) 777-783
39. Semba R., Garrett E., Johnson B., et al. Vitamin D deficiency among older women with and without disability. The American Journal of Clinical Nutrition 72 (2000) 1529-1534
40. Bischoff-Ferrari H., Dawson-Hughes B., Willet W., et al. Effect of vitamin D on falls: a meta-analysis. JAMA 291 (2004) 1999-2006
41. Steingrimsdottir L.G., Indridason O., Franzson L., and Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294 (2005) 2336-2341
42. Tangpricha V., Pearce E., Chen T., and Holick M. Vitamin D insufficiency among free-living healthy young adults. The American Journal of Medicine 112 (2002) 659-662
43. Rosen C., and Brown S. Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. The New England Journal of Medicine 348 (2003) 1503-1504
44. Fox K., Magaziner J., Hawkes W., et al. Loss of bone density and lean body mass after hip fracture. Osteoporosis International 11 (2000) 31-35
45. Klotzbuecher C., Ross P., Landsman P., et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical analysis. Journal of Bone and Mineral Research 15 (2000) 721-739
46. Colon-Emeric C., Kuchibhatla M., Pieper C., et al. The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporosis International 14 (2003) 879-883
47. Torgerson D., and Dolan P. Prescribing by general practitioners after an osteoporotic fracture. Annals of the Rheumatic Diseases 57 (1998) 378-379
48. Colon-Emeric C., Yballe L., Sloane R., et al. Expert physician recommendations and current practice patterns for evaluating and treating men with osteoporotic fracture. Journal of the American Geriatrics Society 48 (2000) 1261-1263
49. Chapuy M., Arlot M., Duboeuf F., et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. The New England Journal of Medicine 327 (1992) 1637-1642
50. Dawson-Hughes B., Harris S., Krall E., and Dallal G. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. The New England Journal of Medicine 337 (1997) 670-676
51. Chestnut C., Skag A., Christiansen C., et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal women. Journal of Bone and Mineral Research 19 (2004) 1241-1249
52. Cranney A., Waldegger L., Zytaruk N., et al. Risedronate for the prevention and treatment of postmenopausal osteoporosis. Cochrane Database of Systematic Reviews 4 (2003) CD004523
53. Bone H., Hosking D.D., Devogelaer J.P., et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women. The New England Journal of Medicine 350 (2004) 1189-1199
54. Greenspan S., Schneider D., McClung M., et al. Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial. Archives of Internal Medicine 136 (2002) 742-746
55. Boonen S., McClung M., Eastell R., et al. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. Journal of the American Geriatrics Society 52 (2004) 1832-1839
56. Colon-Emeric C., Caminis J., Suh T., et al. The HORIZON recurrent fracture trial: design of a clinical trial in the prevention of subsequent fractures after low-trauma hip fracture repair. Current Medical Research and Opinion 20 (2004) 903-910
57. Adolphson P., Abbaszadegan H., Boden H., et al. Clodronate increases mineralization of callus after Colles' fracture: a randomized, double-blind, placebo-controlled, prospective trial in 32 patients. Acta Orthopaedica Scandinavica 71 (2000) 195-200
58. Fleisch H. Can bisphosphonates be given to patients with fractures?. Journal of Bone and Mineral Research 16 (2001) 437-440
59. Jachna C., Shireman T., Whittle J., et al. Differing patterns of antiresorptive pharmacotherapy among nursing facility residents and community dwellers. Journal of the American Geriatrics Society 53 (2005)
60. Chestnut C., Silverman S., Andriano K., et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study. The American Journal of Medicine 109 (2000) 267-276
61. Mehta N., Malootian A., and Gilligan J. Calcitonin for osteoporosis and bone pain. Current Pharmaceutical Design 9 (2003) 2659-2676
62. Neer R., Arnaud C., Zanchetta J., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. The New England Journal of Medicine 344 (2001) 1434-1441
63. Finkelstein J., Hayes A., Hunzelman J., et al. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. The New England Journal of Medicine 349 (2003) 1216-1226
64. Black D., Bilezikian J., Ensrud K., et al. One year of alendronate after one year of parathyroid hormone. The New England Journal of Medicine 353 (2005) 555-565
65. Ettinger B., Black D., Mitlak B., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 282 (1999) 637-645
66. Barret-Connor E., Cauley J., Kulkarni P., et al. Risk-benefit profile for raloxifene: 4-year data from the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Journal of Bone and Mineral Research 19 (2004) 1270-1275
67. Kannus P., Parkkari J., Niemi S., et al. Prevention of hip fracture in elderly people with use of a hip protector. The New England Journal of Medicine 343 (2000) 1506-1513
68. Parker M., Gillespie W., and Gillespie L. Hip protectors for preventing hip fractures in older people. Cochrane Database of Systematic Reviews 3 (2005)
69. Kannus P., Parkkari J., and Poutala J. Comparison of force attenuation properties of four different hip protectors under simulated falling conditions in the elderly: an in vitro biomechanical study. Bone 25 (1999) 229-235
70. Colon-Emeric C., Datta S., and Matchar D. An economic analysis of external hip protector use in ambulatory nursing facility residents. Age and Ageing 32 (2003) 47-52
71. Tinetti M. Preventing falls in elderly persons. The New England Journal of Medicine 348 (2003) 42-49
72. Gillespie L., Gillespie W., Robertson M., et al. Interventions for preventing falls in elderly people. Cochrane Database of Systematic Reviews (2004)
73. Ray W., Taylor J., Meador K., et al. A randomized trial of a consultation service to reduce falls in nursing homes. JAMA 278 (1997) 557-562